ARCHIVES

Arsenic Compound Improves Survival Of Adults With APL

This article is from The Cancer Letter archive.

Vol. 30 No. 2 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: After Nickles Removes Block, Senate Confirms Oncologist Henney As FDA Commissioner

October 23, 1998

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

Okunieff To Lead SWOG Radiation Committee

July 19, 2002

ACS Board Accepts Hammer’s ffer, Will Support Construction Survey

February 17, 1984

Six Comprehensive Center Asked By Candlelighters For Pediatric Cancer

March 24, 1978

NCI-Approved Clinical Trials

February 23, 2007